Phase I study of anti-CD25 mab daclizumab to deplete regulatory T cells prior to telomerase/survivin peptide vaccination in patients (pts) with metastatic breast cancer (MBC).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 2508-2508 ◽  
Author(s):  
A. J. Rech ◽  
R. Mick ◽  
A. Recio ◽  
A. DeMichele ◽  
C. K. Tweed ◽  
...  
2006 ◽  
Vol 12 (23) ◽  
pp. 7071-7078 ◽  
Author(s):  
Christian Dittrich ◽  
Lubos Petruzelka ◽  
Pavel Vodvarka ◽  
Margit Gneist ◽  
Filip Janku ◽  
...  

2016 ◽  
Vol 16 (2) ◽  
pp. 82-86 ◽  
Author(s):  
Winston W. Tan ◽  
Jacob B. Allred ◽  
Alvaro Moreno-Aspitia ◽  
Donald W. Northfelt ◽  
James N. Ingle ◽  
...  

2017 ◽  
Vol 164 (2) ◽  
pp. 359-369 ◽  
Author(s):  
Cornelia von Hagens ◽  
Ingeborg Walter-Sack ◽  
Maren Goeckenjan ◽  
Julia Osburg ◽  
Brigitte Storch-Hagenlocher ◽  
...  

1995 ◽  
Vol 31 ◽  
pp. S80-S81
Author(s):  
M. Spielmann ◽  
G. Catimel ◽  
L. Kayitalire ◽  
P. Pouillart ◽  
A. Dumortier ◽  
...  

Oncology ◽  
2014 ◽  
Vol 86 (4) ◽  
pp. 206-211 ◽  
Author(s):  
Masahiro Kashiwaba ◽  
Toru Inaba ◽  
Hideaki Komatsu ◽  
Kazushige Ishida ◽  
Ryoko Kawagishi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document